A nonsignificant trend toward increased HSCT use was observed among patients assigned to the LDC arm, raising the possibility that reduced induction chemotherapy intensity could expand the pool of transplant candidates.
← all excerpts
Low- vs standard-dose regimens as induction for pediatric AML: a multicenter, randomized noninferiority trial.
1
—
—